{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:53:15Z","timestamp":1761540795284,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.hoc.2007.06.004","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T07:27:28Z","timestamp":1185866848000},"page":"589-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Heparin-Induced Thrombocytopenia"],"prefix":"10.1016","volume":"21","author":[{"given":"Theodore E.","family":"Warkentin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hoc.2007.06.004_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin","year":"2003","journal-title":"Br J\u00a0Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2007.06.004_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"355","author":"Arepally","year":"2006","journal-title":"N Engl J Med"},{"issue":"2\u20133","key":"10.1016\/j.hoc.2007.06.004_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-3848(03)00336-0","article-title":"Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban","volume":"110","author":"Warkentin","year":"2003","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.hoc.2007.06.004_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2007.06.004_bib5","series-title":"Heparin-induced thrombocytopenia","first-page":"21","article-title":"Clinical picture of heparin-induced thrombocytopenia","author":"Warkentin","year":"2007"},{"issue":"20","key":"10.1016\/j.hoc.2007.06.004_bib6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.hoc.2007.06.004_bib7","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.004_bib8","first-page":"132","article-title":"Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients","volume":"94","author":"Greinacher","year":"2005","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.004_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.hoc.2007.06.004_bib10","series-title":"Heparin-induced thrombocytopenia","first-page":"261","article-title":"Pseudo-heparin-induced thrombocytopenia","author":"Warkentin","year":"2007"},{"issue":"8 Pt 1","key":"10.1016\/j.hoc.2007.06.004_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7326\/0003-4819-135-8_Part_1-200110160-00009","article-title":"Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.004_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2004-831039","article-title":"An overview of the heparin-induced thrombocytopenia syndrome","volume":"30","author":"Warkentin","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.004_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.004_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.lab.2005.08.003","article-title":"Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?","volume":"146","author":"Warkentin","year":"2005","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.004_bib15","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.004_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V91.3.916","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis recognize different epitopes on heparin:platelet factor 4","volume":"91","author":"Suh","year":"1998","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2007.06.004_bib17","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.hoc.2007.06.004_bib18","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2007.06.004_bib19","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood-2005-05-1938","article-title":"Anti-platelet factor 4\/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin","volume":"106","author":"Warkentin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.004_bib20","doi-asserted-by":"crossref","unstructured":"Warkentin TE, Eikelboom JW. Who is (still) getting HIT? Chest 2007;131:1620\u20132.","DOI":"10.1378\/chest.07-0425"},{"key":"10.1016\/j.hoc.2007.06.004_bib21","series-title":"Heparin-Induced Thrombocytopenia","first-page":"67","article-title":"Frequency of heparin-induced thrombocytopenia","author":"Lee","year":"2007"},{"issue":"1","key":"10.1016\/j.hoc.2007.06.004_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mob.2001.114690","article-title":"Heparin-induced thrombocytopenia is rare in pregnancy","volume":"185","author":"Fausett","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.hoc.2007.06.004_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMp068309","article-title":"Drug-induced immune-mediated thrombocytopenia: from purpura to thrombosis","volume":"356","author":"Warkentin","year":"2007","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.hoc.2007.06.004_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J\u00a0Med"},{"issue":"7","key":"10.1016\/j.hoc.2007.06.004_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.004_bib26","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2007.06.004_bib27","doi-asserted-by":"crossref","first-page":"311a","DOI":"10.1182\/blood.V108.11.1047.1047","article-title":"Platelet-activating anti-platelet factor 4\/polyanion antibodies without preceding heparin therapy: a transient autoimmune disorder resembling heparin-induced thrombocytopenia (\u201cspontaneous HIT\u201d)","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.004_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/asheducation-2006.1.408","article-title":"Think of HIT","author":"Warkentin","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.hoc.2007.06.004_bib29","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2005-05-1824","article-title":"Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia","volume":"106","author":"Greinacher","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.004_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1378\/chest.130.3.631","article-title":"Think of HIT when thrombosis follows heparin","volume":"130","author":"Warkentin","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.hoc.2007.06.004_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1365-2141.1996.d01-1481.x","article-title":"Heparin-induced skin lesions","volume":"92","author":"Warkentin","year":"1996","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.004_bib32","first-page":"489","article-title":"Transient global amnesia following intravenous heparin bolus therapy is caused by heparin-induced thrombocytopenia","volume":"97","author":"Warkentin","year":"1994","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.004_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hoc.2007.06.004_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tmrv.2006.05.001","article-title":"Testing for heparin-induced thrombocytopenia antibodies","volume":"20","author":"Warkentin","year":"2006","journal-title":"Transfus Med Rev"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2007.06.004_bib35","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1378\/chest.127.2_suppl.35S","article-title":"New approaches to the diagnosis of heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2007.06.004_bib36","unstructured":"Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol, in press."},{"issue":"3","key":"10.1016\/j.hoc.2007.06.004_bib37","first-page":"371","article-title":"Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia","volume":"120","author":"Warkentin","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.004_bib38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-induced thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2007.06.004_bib39","doi-asserted-by":"crossref","unstructured":"Greinacher A, Juhl D, Strobel U, et\u00a0al. Heparin-induced thrombocytopenia: a prospective\u00a0study on the incidence, platelet-activating capacity and clinical significance of anti-PF4\/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 2007; May 7 [epub ahead of print].","DOI":"10.1111\/j.1538-7836.2007.02617.x"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2007.06.004_bib40","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"issue":"18","key":"10.1016\/j.hoc.2007.06.004_bib41","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1161\/01.CIR.0000147537.72829.1B","article-title":"Heparin-induced thrombocytopenia: diagnosis and management","volume":"110","author":"Warkentin","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hoc.2007.06.004_bib42","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1055\/s-0037-1616046","article-title":"Prospective randomized open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis: a clinical outcome study","volume":"86","author":"Chong","year":"2001","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.hoc.2007.06.004_bib43","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1538-7836.2005.01623.x","article-title":"Lepirudin in patients with heparin-induced thrombocytopenia\u2014results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3","volume":"3","author":"Lubenow","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hoc.2007.06.004_bib44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V96.3.846","article-title":"Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of two prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.hoc.2007.06.004_bib45","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hoc.2007.06.004_bib46","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.hoc.2007.06.004_bib47","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.129.6.1407","article-title":"Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia","volume":"129","author":"Lewis","year":"2006","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.hoc.2007.06.004_bib48","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/blood-2004-02-0621","article-title":"Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies","volume":"104","author":"Lubenow","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2007.06.004_bib49","series-title":"Heparin-induced thrombocytopenia","first-page":"283","article-title":"Treatment of heparin-induced thrombocytopenia: an overview","author":"Greinacher","year":"2007"},{"key":"10.1016\/j.hoc.2007.06.004_bib50","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1538-7836.2006.01875.x","article-title":"Should vitamin K be administered when HIT is diagnosed after administration of coumarin?","volume":"4","author":"Warkentin","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:49:36Z","timestamp":1760183376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985880700069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S088985880700069X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2007.06.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-Induced Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2007.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}